1. Pink Sheet
  2. >>Geography
  3. >>Europe

BTG Makes Two Buys To Build Interventional Medicine Business

 
• By Sten Stovall

BTG of Britain plans two new acquisitions, including a therapy for liver cancer that uses radioactive glass beads and a treatment for dissolving severe blood clots. The deals create an interventional medicine business with potential sales of $1 billion; BTG is funding much of the exercise through a share placement.

U.K.-based specialty pharma BTG PLC is making a double acquisition of two fast-growing, profitable interventional medicine businesses for a combined consideration of about $380 million, reflecting a rising focus on therapies and medical devices.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United Kingdom

More from Europe